95 filings
Page 4 of 5
6-K
bbzq090t jc9
7 Dec 20
Current report (foreign)
10:14am
6-K
ykpf7moc
6 Nov 20
ERYTECH Announces Abstract with Results from Eryaspase
9:24am
6-K
owcwigejakws
3 Nov 20
ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government
4:33pm
6-K
pmsy7fct8g03vr
22 Sep 20
ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020
12:00am
6-K
ao1e3kzgrh35e
21 Sep 20
I. Certification of the Person Responsible for the Half-year Financial Report
6:09am
6-K
y6ix58
15 Sep 20
ERYTECH Announces the Hosting of a KOL Event as the TRYbeCA-1 Phase 3 Trial in Second-line Pancreatic Cancer Nears Complete Enrollment
7:32am
6-K
xhvn29xl5o72tersh84w
26 Jun 20
Current report (foreign)
5:10pm
6-K
0pn5sunjool
25 Jun 20
Current report (foreign)
4:31pm
6-K
2pe1 kniv
9 Jun 20
ERYTECH Provides Update on Phase 2 Investigator
4:11pm
6-K
0v5ax9z1comkde t1bz
2 Jun 20
ERYTECH Announces Poster Presentations
5:07pm
6-K
lhb7yv1spl8djwp
26 May 20
Erytech’s Combined Shareholders’ Meeting
4:40pm
6-K
1gdwexvpkf9
8 May 20
ERYTECH Provides Business Update and Reports Cash Balance at End of Q1 2020
4:08pm
6-K
915kv41kh5jhc3
30 Apr 20
ERYTECH Granted U.S. FDA Fast Track Designation
7:59am
6-K
uepbabt4qfmvmtb
21 Apr 20
ERYTECH Provides Update on theTRYbeCA-1
7:06am
6-K
iwtu2vkth8
17 Mar 20
ERYTECH Announces the Appointment of
4:25pm
6-K
gm7s3m
6 Feb 20
Current report (foreign)
4:16pm
6-K
dnts 7uksn
8 Nov 19
ERYTECH Provides Business Update and Reports Financial Results for the Third Quarter of 2019
8:44am
6-K
4pgvhajmc1481 vo
26 Sep 19
Half-year Financial Report
4:14pm
6-K
pbikv w8nk
18 Sep 19
Reports Financial Results for the First Half of 2019
9:30am
6-K
1x44j2ol gqu6xhkpm
16 Jul 19
ERYTECH Pharma Reports Voting Results from Annual
4:27pm